19 related articles for article (PubMed ID: 29634103)
1. Replicates Number for Drug Stability Testing during Bioanalytical Method Validation-An Experimental and Retrospective Approach.
Gniazdowska E; Goch W; Giebułtowicz J; Rudzki PJ
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056772
[TBL] [Abstract][Full Text] [Related]
2. Quantification of imatinib in human serum: validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays.
Rezende VM; Rivellis A; Novaes MM; de Alencar Fisher Chamone D; Bendit I
Drug Des Devel Ther; 2013; 7():699-710. PubMed ID: 23946646
[TBL] [Abstract][Full Text] [Related]
3. Population Pharmacokinetic Analysis of the Oral Absorption Process and Explaining Intra-Subject Variability in Plasma Exposures of Imatinib in Healthy Volunteers.
Golabchifar AA; Rezaee S; Dinan NM; Kebriaeezadeh A; Rouini MR
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):527-39. PubMed ID: 26189007
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous quantification of imatinib and its main metabolite N-demethyl-imatinib in human plasma by liquid chromatography-tandem mass spectrometry and its application to therapeutic drug monitoring in patients with gastrointestinal stromal tumor.
Zhuang W; Qiu HB; Chen XM; Yuan XH; Yang LF; Sun XW; Zhou XJ; Huang M; Wang XD; Zhou ZW
Biomed Chromatogr; 2017 Dec; 31(12):. PubMed ID: 28621487
[TBL] [Abstract][Full Text] [Related]
5. Method development and validation for the simultaneous determination of imatinib mesylate and N-desmethyl imatinib using rapid resolution high performance liquid chromatography coupled with UV-detection.
Tan KL; Ankathil R; Gan SH
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3583-91. PubMed ID: 22000961
[TBL] [Abstract][Full Text] [Related]
6. Field-assisted paper spray mass spectrometry for therapeutic drug monitoring: 1. the case of imatinib in plasma.
D'Aronco S; Dall'Armi M; Crotti S; Calandra E; Traldi P; Di Marco V; Buonadonna A; Corona G; Giodini L; Marangon E; Posocco B; Toffoli G; Agostini M
J Mass Spectrom; 2017 May; 52(5):283-289. PubMed ID: 28251731
[TBL] [Abstract][Full Text] [Related]
7. HPLC-UV ASSAY OF IMATINIB IN HUMAN PLASMA OPTIMIZED FOR BIOEQUIVALENCE STUDIES.
Kaza M; Piorkowska E; Filist M; Rudzki PJ
Acta Pol Pharm; 2016 Nov; 73(6):1495-1503. PubMed ID: 29634103
[TBL] [Abstract][Full Text] [Related]
8. Towards point of care systems for the therapeutic drug monitoring of imatinib.
Pearce CM; Resmini M
Anal Bioanal Chem; 2020 Sep; 412(24):5925-5933. PubMed ID: 32166445
[TBL] [Abstract][Full Text] [Related]
9. Routine therapeutic drug monitoring of tyrosine kinase inhibitors by HPLC-UV or LC-MS/MS methods.
Miura M; Takahashi N
Drug Metab Pharmacokinet; 2016 Feb; 31(1):12-20. PubMed ID: 26732608
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
